China · Delayed Price · Currency is CNY Beijing SL Pharmaceutical Statistics
Total Valuation
SHE:002038 has a market cap or net worth of CNY 6.45 billion. The enterprise value is 5.32 billion.
| Market Cap | 6.45B |
| Enterprise Value | 5.32B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
SHE:002038 has 1.03 billion shares outstanding. The number of shares has decreased by -8.40% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | -8.40% |
| Shares Change (QoQ) | +7.46% |
| Owned by Insiders (%) | 22.73% |
| Owned by Institutions (%) | 2.64% |
| Float | 634.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.91 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | 21.17 |
| P/OCF Ratio | 17.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.42, with an EV/FCF ratio of 17.45.
| EV / Earnings | -11.09 |
| EV / Sales | 8.53 |
| EV / EBITDA | 33.42 |
| EV / EBIT | n/a |
| EV / FCF | 17.45 |
Financial Position
The company has a current ratio of 3.38
| Current Ratio | 3.38 |
| Quick Ratio | 2.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.97% and return on invested capital (ROIC) is 0.33%.
| Return on Equity (ROE) | -8.97% |
| Return on Assets (ROA) | 0.14% |
| Return on Invested Capital (ROIC) | 0.33% |
| Return on Capital Employed (ROCE) | 0.25% |
| Weighted Average Cost of Capital (WACC) | 4.79% |
| Revenue Per Employee | 656,591 |
| Profits Per Employee | -531,943 |
| Employee Count | 901 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.45 |
Taxes
In the past 12 months, SHE:002038 has paid 51.13 million in taxes.
| Income Tax | 51.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.80% in the last 52 weeks. The beta is 0.10, so SHE:002038's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -7.80% |
| 50-Day Moving Average | 6.83 |
| 200-Day Moving Average | 7.39 |
| Relative Strength Index (RSI) | 38.68 |
| Average Volume (20 Days) | 52,511,905 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002038 had revenue of CNY 591.59 million and -479.28 million in losses. Loss per share was -0.48.
| Revenue | 591.59M |
| Gross Profit | 373.72M |
| Operating Income | 13.22M |
| Pretax Income | -429.96M |
| Net Income | -479.28M |
| EBITDA | 183.44M |
| EBIT | 13.22M |
| Loss Per Share | -0.48 |
Balance Sheet
The company has 1.16 billion in cash and n/a in debt, with a net cash position of 1.16 billion or 1.13 per share.
| Cash & Cash Equivalents | 1.16B |
| Total Debt | n/a |
| Net Cash | 1.16B |
| Net Cash Per Share | 1.13 |
| Equity (Book Value) | 5.10B |
| Book Value Per Share | 4.73 |
| Working Capital | 1.44B |
Cash Flow
In the last 12 months, operating cash flow was 372.31 million and capital expenditures -67.50 million, giving a free cash flow of 304.81 million.
| Operating Cash Flow | 372.31M |
| Capital Expenditures | -67.50M |
| Depreciation & Amortization | 170.22M |
| Net Borrowing | n/a |
| Free Cash Flow | 304.81M |
| FCF Per Share | 0.30 |
Margins
Gross margin is 63.17%, with operating and profit margins of 2.23% and -81.02%.
| Gross Margin | 63.17% |
| Operating Margin | 2.23% |
| Pretax Margin | -72.68% |
| Profit Margin | -81.02% |
| EBITDA Margin | 31.01% |
| EBIT Margin | 2.23% |
| FCF Margin | 51.52% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.15%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.15% |
| Dividend Growth (YoY) | -86.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.40% |
| Shareholder Yield | 8.55% |
| Earnings Yield | -7.43% |
| FCF Yield | 4.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 4, 2019 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |